Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2006-2-6
pubmed:abstractText
Although a majority of metastatic prostate cancer lesions are osteoblastic in nature, some are mixed or lytic; and, osteoblastic lesions require osteolytic activity in order to progress. The role of BMPs in the formation of prostate cancer metastases to bone remains unknown. We hypothesized that BMPs influence the development and progression of osteolytic prostate cancer lesions.
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/BMP2 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/BMP4 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/BMP7 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Bmp2 protein, mouse, http://linkedlifedata.com/resource/pubmed/chemical/Bmp2 protein, rat, http://linkedlifedata.com/resource/pubmed/chemical/Bmp4 protein, mouse, http://linkedlifedata.com/resource/pubmed/chemical/Bmp4 protein, rat, http://linkedlifedata.com/resource/pubmed/chemical/Bmp7 protein, rat, http://linkedlifedata.com/resource/pubmed/chemical/Bone Morphogenetic Protein 2, http://linkedlifedata.com/resource/pubmed/chemical/Bone Morphogenetic Protein 4, http://linkedlifedata.com/resource/pubmed/chemical/Bone Morphogenetic Protein 7, http://linkedlifedata.com/resource/pubmed/chemical/Bone Morphogenetic Protein Receptors, http://linkedlifedata.com/resource/pubmed/chemical/Bone Morphogenetic Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Carrier Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta, http://linkedlifedata.com/resource/pubmed/chemical/noggin protein
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
8756-3282
pubmed:author
pubmed:issnType
Print
pubmed:volume
38
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
154-66
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:16126463-Animals, pubmed-meshheading:16126463-Bone Morphogenetic Protein 2, pubmed-meshheading:16126463-Bone Morphogenetic Protein 4, pubmed-meshheading:16126463-Bone Morphogenetic Protein 7, pubmed-meshheading:16126463-Bone Morphogenetic Protein Receptors, pubmed-meshheading:16126463-Bone Morphogenetic Proteins, pubmed-meshheading:16126463-Bone Neoplasms, pubmed-meshheading:16126463-Carrier Proteins, pubmed-meshheading:16126463-Cell Line, Tumor, pubmed-meshheading:16126463-Cell Movement, pubmed-meshheading:16126463-Cell Proliferation, pubmed-meshheading:16126463-Disease Progression, pubmed-meshheading:16126463-Gene Expression, pubmed-meshheading:16126463-Humans, pubmed-meshheading:16126463-Male, pubmed-meshheading:16126463-Mice, pubmed-meshheading:16126463-Mice, SCID, pubmed-meshheading:16126463-Neoplasm Metastasis, pubmed-meshheading:16126463-Neoplasm Transplantation, pubmed-meshheading:16126463-Osteoclasts, pubmed-meshheading:16126463-Osteolysis, pubmed-meshheading:16126463-Prostatic Neoplasms, pubmed-meshheading:16126463-Rats, pubmed-meshheading:16126463-Transfection, pubmed-meshheading:16126463-Transforming Growth Factor beta, pubmed-meshheading:16126463-Xenograft Model Antitumor Assays
pubmed:year
2006
pubmed:articleTitle
Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions.
pubmed:affiliation
Department of Orthopaedic Surgery, David Geffen School of Medicine at UCLA, Center for Health Sciences 76-134, 10833 LeConte Avenue, Los Angeles, CA 90095, USA. bfeeley@mednet.ucla.edu
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural